What is PKD Foundation?
Established in 1982, the PKD Foundation operates as the sole national organization in the United States exclusively focused on the eradication of polycystic kidney disease. The entity functions as a critical nexus for research funding, patient advocacy, and community support. By prioritizing the development of novel treatments for this chronic, genetic condition, the foundation addresses a significant unmet medical need. Its operational model integrates direct community services with high-impact research grants, effectively mobilizing resources to combat a disease that currently lacks a definitive cure.
How much funding has PKD Foundation raised?
PKD Foundation has raised a total of $831K across 2 funding rounds:
Debt
$350K
Debt
$481K
Debt (2020): $350K with participation from PPP
Debt (2021): $481K led by PPP
Key Investors in PKD Foundation
PPP
Public-Private Partnership
What's next for PKD Foundation?
With the recent influx of capital, the PKD Foundation is poised to scale its research initiatives and expand its advocacy footprint. The strategic deployment of these funds will likely focus on diversifying the pipeline of potential therapies and enhancing the infrastructure for clinical trials. As the organization moves forward, the emphasis will remain on translating laboratory discoveries into tangible patient outcomes, while simultaneously strengthening the national support network for those affected by the disease. This phase of growth is critical for sustaining the momentum required to move closer to a viable cure for PKD.
See full PKD Foundation company page
